BridgeMD
New treatment option for Chronic Pain
Official title Mindfulness And Placebo for Pain (MAPP) Study
ClinicalTrials.gov ID: NCT06720909
What this study is testing
- What it's testing
- This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥18 years old;
- ability to speak, write, and read in English;
- physical pain present on at least half the days in the past 3 months; and
- average past week pain severity rating ≥3 on a 0-10 Numerical Rating Scale.
You likely can't join if
- acute pain due to recent injury or surgery;
- self-reporting of chronic malignant pain (e.g., cancer, HIV);
- self-reporting of Raynaud's disease (those who can be contraindicated for cold pressor testing);
- severe psychopathology (e.g., a psychotic disorder) or significant cognitive deficits judged to interfere with study procedures;
- currently pregnant or breastfeeding;
- inability to discontinue use of vitamin B2 supplements or a multivitamin containing vitamin B2 throughout the study period (these interfere with...
See the full eligibility criteria
- ≥18 years old;
- ability to speak, write, and read in English;
- physical pain present on at least half the days in the past 3 months; and
- average past week pain severity rating ≥3 on a 0-10 Numerical Rating Scale.
- acute pain due to recent injury or surgery;
- self-reporting of chronic malignant pain (e.g., cancer, HIV);
- self-reporting of Raynaud's disease (those who can be contraindicated for cold pressor testing);
- severe psychopathology (e.g., a psychotic disorder) or significant cognitive deficits judged to interfere with study procedures;
- currently pregnant or breastfeeding;
- inability to discontinue use of vitamin B2 supplements or a multivitamin containing vitamin B2 throughout the study period (these interfere with riboflavin tracer-OLP treatment adherence-monitoring);
- inability to commit to study period.
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.